DONNA BAMBACH: Open Payments
NPI 1629702568 · ALEXANDRIA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$826 in 35 payments from 12 companies in 2025. Trend: 2023 $940 · 2024 $809 · 2025 $826
Food & beverage: $826
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $273 |
| ABBVIE INC. | 5 | $130 |
| PFIZER INC. | 5 | $107 |
| Astellas Pharma US Inc | 3 | $67 |
| Lilly USA, LLC | 3 | $66 |
| Amgen Inc. | 2 | $51 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Abbott Laboratories | 1 | $20 |
| Exact Sciences Corporation | 1 | $20 |
Products named: Ozempic, QULIPTA, NURTEC ODT, Veozah, Rybelsus, ELIQUIS, Wegovy, OTEZLA.
Industry payments across VA — which companies pay providers there.
